Overview
Kardia personal ECG devices (KardiaMobile, KardiaMobile 6L, Kardia 12L) and KAI AI algorithms detecting arrhythmias, ischemia patterns, and morphology findings; KardiaPro and KardiaStation enterprise software for provider monitoring and clinical trials.
Product and company
Kardia personal ECG devices (KardiaMobile is a verified product offering linked to the Brel Digital company profile for AliveCor.
Use cases
Kardia personal ECG devices (KardiaMobile, KardiaMobile 6L, Kardia 12L) and KAI AI algorithms detecting arrhythmias, ischemia patterns, and morphology findings; KardiaPro and KardiaStation enterprise software for provider monitoring and clinical trials.
Target customer
Consumers, employers, health systems, life-sciences sponsors, and veterans health programs needing portable ECG acquisition with AI interpretation in outpatient, acute, and remote monitoring settings.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Predictive Analytics.
Sources and references
- Official product / company source: https://alivecor.com/press/press_release/alivecor-announces-fda-clearance-new-cardiac-determinations-kardia-12l-ecg-system
- Supporting source: https://alivecor.com/about/leadership
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- Kardia personal ECG devices (KardiaMobile, KardiaMobile 6L, Kardia 12L) and KAI AI algorithms detecting arrhythmias, isch
- KardiaPro and KardiaStation enterprise software for provider monitoring and clinical trials
Extracted from the linked company product description already verified on Brel. No capabilities were invented.